Tina Flatau
Directeur/Membre du Conseil chez Sixfold Bioscience, Inc.
Postes actifs de Tina Flatau
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sixfold Bioscience, Inc.
Sixfold Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sixfold Bioscience Ltd., Sixfold Bioscience, Inc. operates as a biotechnology company that develops next-generation in vivo delivery systems for RNA therapeutics. The company is based in Walnut, CA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Tina Flatau
Anciens postes connus de Tina Flatau
Sociétés | Poste | Début | Fin |
---|---|---|---|
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Directeur Général | 01/01/2016 | 01/03/2019 |
PROSENSA HOLDING NV | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Pays-Bas | 2 |
Royaume-Uni | 2 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Sectorielle
Commercial Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Sixfold Bioscience, Inc.
Sixfold Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sixfold Bioscience Ltd., Sixfold Bioscience, Inc. operates as a biotechnology company that develops next-generation in vivo delivery systems for RNA therapeutics. The company is based in Walnut, CA. | Commercial Services |
- Bourse
- Insiders
- Tina Flatau
- Expérience